Mark J. Foley - President & CEO, Director at Revance Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Issuer Symbol
RVNC
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark J. Foley since 10 Mar 2025

Holdings reported by Mark J. Foley for Revance Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $0 $3.65 06 Feb 2025 Direct
Common Stock 0 $0 $3.65 04 Feb 2025 Indirect

Transactions reported by Mark J. Foley for Revance Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.